eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neutropenia |
| Comorbidity | C0242379|lung cancer |
| Sentences | 8 |
| PubMedID- 21707992 | Results: the study included 87 lung cancer patients with febrile neutropenia (mean age: 64.2). |
| PubMedID- 21773751 | In this study, we tried to identify the risk factors for refractory febrile neutropenia in patients with lung cancer. |
| PubMedID- 26434104 | Pentraxin-3 as a biomarker for febrile neutropenia in patients with lung cancer. |
| PubMedID- 24679653 | We assessed the efficacy and safety of cefepime monotherapy (1 g intravenously every 8 h) for febrile neutropenia in patients with lung cancer in a multi-institutional phase ii study. |
| PubMedID- 23489558 | Clinicians should be aware that gefitinib-induced neutropenia in patients with non-small cell lung cancer can be treated successful by switching to erlotinib. |
| PubMedID- 22133387 | The highest incidence of severe neutropenia was found in patients with non-small cell lung cancer (61%; 95% ci 50, 74), while the lowest incidence was seen in patients with squamous cell carcinoma of the esophagus (22%; 95% ci 11, 45). |
| PubMedID- 23173291 | [febrile neutropenia in lung cancer patients]. |
| PubMedID- 23053498 | Elevation of serum c-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer. |
Page: 1